StonvexLoading…
StonvexStonvexStonvexCore line items from MRVL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-05-02 | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 |
|---|---|---|---|---|
Revenue | $2.42B | $8.19B | $5.98B | $3.90B |
Operating Income | $339.40M | $1.32B | $918.50M | $560.70M |
Net Income | $34.50M | $2.67B | $2.27B | $194.80M |
EPS (Diluted) | $0.04 | $3.07 | $2.61 | $0.43 |
Total Assets | $26.94B | $22.29B | $21.58B | $20.59B |
Total Liabilities | $8.73B | $7.98B | $7.52B | $7.16B |
Cash & Equivalents | $3.84B | $2.64B | $2.71B | $1.22B |
Free Cash Flow OCF − CapEx | $483.10M | $1.40B | $1.14B | $628.20M |
Shares Outstanding | 893.30M | 847.30M | 869.90M | 873.00M |